Browsing Molekulare Medizin by Referee "Brück, Wolfgang Prof. Dr."
Now showing items 1-14 of 14
-
The role of the astrocytic and microglial aryl hydrocarbon receptor in CNS demyelination
(2020-11-26)The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor which plays a key role in the regulation of immune and inflammatory responses. AhR expression in astrocytes and microglia was shown to limit ... -
Dysferlin in skeletal and heart muscle: from trafficking to therapy
(2017-09-19)Dysferlinopathies are a heterogeneous group of congenital muscle disorders characterized by late-onset muscular dystrophy and increased muscle prowess before onset of symptoms. Mutations in the DYSF gene encoding the protein ... -
Modulation of remyelination by adaptive inflammation and electrical stimulation
(2017-06-29)Multiple sclerosis (MS) is a chronic, inflammatory demyelinating disease of the central nervous system (CNS). Typical characteristics of MS are blood-brain barrier (BBB) breakdown, invasion of peripheral immune cells, ... -
Effects of dimethyl fumarate in two animal models of MS
(2017-04-25)MS is a heterogeneous disease characterized by transient and later permanent disability caused by inflammatory CNS lesions with profound axonal loss and demyelination. Although the exact pathogenesis of the disease is still ... -
IFNβ as regulator of CD14/TLR4-mediated microglial responses to CNS infection and damage
(2017-02-15)Microglia are the innate immune cells of the central nervous system (CNS). They are capable of sensing infection and damage through various receptors and consequently trigger an appropriate immune response. This includes ... -
Constitutive heterogeneity and response diversity of microglia in pathological conditions
(2016-12-16)Microglia, resident myeloid cells of the CNS, execute an enormous variety of different functions like tissue surveillance, nursing of synapses, phagocytosis of foreign material or debris, and initiation of appropriate ... -
The role of astrocytes in murine models of toxic demyelination
(2016-08-30)In demyelinating diseases such as multiple sclerosis (MS) activated astrocytes, characterised by up-regulation of the intermediate filament glial fibrillary acidic protein (GFAP), were shown to have beneficial as well as ... -
Immunopathogenesis of cortical demyelination in Multiple Sclerosis
(2015-11-20)Cortical demyelination is a key pathological feature of multiple sclerosis (MS) and clinically linked to cognitive deficits and disability progression. Extensive band-like subpial demyelination is even a specific feature ... -
Characterization of blood-brain barrier disruption in a focal model of neuromyelitis optica
(2015-11-20)Neuromyelitis optica (NMO) is a demyelinating autoimmune disease of the central nervous system (CNS), with serum anti-aquaporin4 (AQP4) antibodies (Ab) detected in the majority of patients. Binding of NMO-Ab to AQP4 results ... -
rAAV-based gene therapy for molybdenum cofactor deficiency type B
(2015-06-29)Molybdenum cofactor (MoCo) deficiency type A is thus far only one curable type of MoCo deficiency. In the present study, a mouse model for MoCo deficiency type B (Mocs2-/-) was generated, characterised and used for preclinical ... -
The role of astrocytic RFX4_v3 in demyelination
(2015-05-11)RFX4_v3 is the brain-specific splice variant of the transcription factor RFX4 (Blackshear et al., 2003; Matsushita et al., 2005). It was shown to play an important role during early brain development and in the genesis of ... -
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
(2015-02-17)Axonal damage, often followed by axonal degeneration, is the main cause of persisting disabilities in multiple sclerosis (MS) patients and already occurs in early stages of the disease. Disease progression is in addition ... -
Analyzing the effects of laquinimod on innate and adaptive immunity in mice with experimental autoimmune encephalomyelitis
(2014-05-09)Laquinimod (LAQ), a new orally active immunomodulator, is currently under investigation for the treatment of multiple sclerosis (MS). In clinical trials LAQ considerably reduced the annualized relapse rate, disability ... -
Impact of natalizumab therapy on human pathology and an animal model of multiple sclerosis (EAE) with special focus on B cell / plasma cell inflammation
(2014-03-13)Multiple sclerosis (MS) is considered to be a T cell-mediated demyelinating disease. However, there is increasing evidence for the involvement of B cells and plasma cells in MS pathogenesis: for instance, B cells and plasma ...